DEAC, SE
CAS No. 139346-57-9
DEAC, SE( —— )
Catalog No. M35844 CAS No. 139346-57-9
DEAC, SE can be used for relevant research in the field of life sciences. Its product number is T64949 and CAS number is 139346-57-9.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 276 | In Stock |
|
| 100MG | 426 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 918 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDEAC, SE
-
NoteResearch use only, not for human use.
-
Brief DescriptionDEAC, SE can be used for relevant research in the field of life sciences. Its product number is T64949 and CAS number is 139346-57-9.
-
DescriptionDEAC, SE (7-Diethylaminocoumarin-3-carboxylic acid, SE) is an excellent blue fluorescent building block for labeling amine-containing biomolecules.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number139346-57-9
-
Formula Weight358.35
-
Molecular FormulaC18H18N2O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (46.52 mM; Ultrasonic (<60°C)
-
SMILESCCN(CC)c1ccc2cc(C(=O)ON3C(=O)CCC3=O)c(=O)oc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MSH-B
MSH-B
-
2,6-Dihydroxypurine
A purine base found in most body tissues and fluids, certain plants, and some urinary calculi.
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
Cart
sales@molnova.com